Abbott Laboratories (ABT US): Q42021 Review- Conservative Guidance Leaves Room For Upside Potential
Strong base business, conservative 2022 guidance leaving room for upside potential, cadence of new product launches, and resilient pockets of...
174 Views
MicroTech (微泰医疗) IPO: Demanding Valuation Despite a Decent Story
We provided an update for the book building of MicroTech Medical which sells diabetes management products including patch insulin pump (Equil) and...
229 Views
MicroTech (微泰医疗) Pre-IPO: Thoughts on Valuation
In this note, we provide a financial forecast for the MicroTech's main products (Equil, BGMS, CGMS) and our thoughts on the pre-money valuation.
246 Views
Tesla: S&P500 Inclusion Secured?
On 22 July, Tesla Motors (TSLA US) reported a profit for Q2 2020 making it the fourth consecutive quarterly profit. Hitting that milestone makes...
553 Views
U.S. Equity Strategy: Several Indicators Suggest a Pullback Likely
Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight...
433 Views